Results 251 to 260 of about 107,123 (321)

Revisiting low penetrance retinoblastoma: an integrated clinical, genetic, and bioinformatic analysis. [PDF]

Hum Mol Genet
Avnat E, Shapira G, Lustig Y, Citrin J, Rojanaporn D, Kaewkhaw R, Jo DH, Kim JH, Shomron N, Friedman E, Fabian ID.   +10 more
europepmc   +1 more source

Prognostic and therapeutic roles of specific genotypes through target-gene sequencing on gastroenteropancreatic neuroendocrine carcinoma. [PDF]

Oncologist
Zhang J, Zhang P, Zhang Y, Hu Q, Li J, Zhang X, Li J, Wang X, Zhou J, Lu Z, Peng Z, Sun Y, Wang S, Lu M, Shen L.   +14 more
europepmc   +1 more source

RB1 Gene Alteration Positive [PDF]

, 2020
openaire   +1 more source

Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads? [PDF]

Front Oncol
Valerio MR, Scandurra G, Greco M, Mesi C, Gebbia V, Sambataro D.   +5 more
europepmc   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities. [PDF]

Front Immunol
Xu L, Wang B, Li W, Luo X, Wang L, Zheng Y.   +5 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Ginsenoside Rb1-engineered nanocomposite hydrogel promotes pressure injury repair through SIRT1-AMPK-mediated ferroptosis inhibition and angiogenesis activation. [PDF]

J Ginseng Res
Zhu H, Li H, Shi Y, Liu J, Zhi H, Zhao X, Wang Z, Ping F.   +7 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source